Update on management of patients with overt hepatic encephalopathy.

Hospital practice (1995)

Volumn 41, Issue 3, 2013, Pages 48-59

  Chacko, Kristina R ^a   Sigal, Samuel H ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL AGENT; LACTULOSE; RIFAMYCIN; RIFAXIMIN;

COMPLICATION; DISEASE MANAGEMENT; DRUG COMBINATION; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX;

DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; GASTROINTESTINAL AGENTS; HEPATIC ENCEPHALOPATHY; HUMANS; LACTULOSE; LIVER CIRRHOSIS; RIFAMYCINS; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX;

EID: 84891674581     PISSN: 21548331     EISSN: None     Source Type: Journal    
DOI: 10.3810/hp.2013.08.1068     Document Type: Review

References (0)